xoph5
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01723241)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- xaf5
- xoph5
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02607683 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2016 | Allergan, Topokine Therapeutics |
| NCT02230761 | Phase 2 | Sep 1, 2014 | Topokine Therapeutics |
| NCT01990326 | Phase 2 | Nov 1, 2013 | Topokine Therapeutics |
| NCT01723241 | Phase 1 | Nov 1, 2012 | Topokine Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Topokine Therapeutics | For profit | 4 | 4 | 3 | 2012 |
| Allergan | For profit | 1 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1